| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
2 companies
Gibson Christopher is a Director at RECURSION PHARMACEUTICALS, INC. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 45 sells.
Estimated insider holdings value: $3.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 22, 2022 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 80,108 | $6.17 | $494,275.02 | -4.4% | +41.5% | -4.7% | |
| Apr 18, 2022 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 38,336 | $6.83 | $261,841.92 | -4.6% | +22.8% | -9.0% | |
| Apr 14, 2022 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 37,017 | $7.55 | $279,630.13 | -4.8% | +9.0% | -20.4% | |
| Apr 8, 2022 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 39,420 | $6.60 | $259,991.26 | -5.5% | +35.2% | -2.0% | |
| Apr 7, 2022 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 39,218 | $6.54 | $256,519.87 | -5.9% | +35.0% | -0.6% | |
| Apr 6, 2022 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 38,326 | $6.76 | $259,118.73 | -6.2% | +33.1% | 0.0% | |
| Apr 5, 2022 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 36,972 | $7.43 | $274,517.73 | -6.6% | +24.3% | -9.4% | |
| Mar 15, 2022 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 336,150 | $6.48 | $2,176,801.38 | -32.4% | -7.2% | +19.7% | |
| Mar 7, 2022 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 300,000 | $7.30 | $2,188,950.00 | -56.2% | +1.1% | +16.4% | |
| Feb 22, 2022 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 100,000 | $10.22 | $1,021,540.00 | -29.9% | -42.9% | -21.9% |